speb/financial-data huggingface dataset:
TIR.L cash_flow (annual, 2024-12-31) — Sale Of Investment: 87552.00
TIR.L income_statement (annual, 2024-12-31) — Selling General And Administration: 154608.00
TIR.L balance_sheet (annual, 2024-12-31) — Share Issued: 539628554.00
TIR.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 539628554.00
TIR.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: -237413.00
TIR.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -237413.00
TIR.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: -237413.00
TIR.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -237413.00
TIR.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
TIR.L income_statement (annual, 2024-12-31) — Tax Provision: 0.00
TIR.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
TIR.L balance_sheet (annual, 2024-12-31) — Total Assets: 226267.00
TIR.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 226267.00
TIR.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -237413.00
TIR.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -237413.00
TIR.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 463680.00
TIR.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 463680.00
TIR.L balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 450000.00
TIR.L balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 450000.00
TIR.L balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 777793.00
TIR.L income_statement (annual, 2025-12-31) — +Operating Expense: 1246409.00
TIR.L income_statement (annual, 2025-12-31) — +Total Revenue: -477594.00
TIR.L balance_sheet (annual, 2025-12-31) — Accounts Payable: 54331.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 54331.00
TIR.L balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2812109.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2812109.00
TIR.L income_statement (annual, 2025-12-31) — Basic Average Shares: 431686297.00
TIR.L income_statement (annual, 2025-12-31) — Basic EPS: 0.00
TIR.L cash_flow (annual, 2025-12-31) — Beginning Cash Position: 23457.00
TIR.L balance_sheet (annual, 2025-12-31) — Capital Stock: 4406108.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4406108.00
TIR.L balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 751994.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 751994.00
TIR.L balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 751994.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 751994.00
TIR.L cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
TIR.L cash_flow (annual, 2025-12-31) — Change In Payable: -333449.00
TIR.L cash_flow (annual, 2025-12-31) — Change In Receivables: -11156.00
TIR.L cash_flow (annual, 2025-12-31) — Change In Working Capital: -344605.00
TIR.L cash_flow (annual, 2025-12-31) — Changes In Cash: 728537.00
TIR.L balance_sheet (annual, 2025-12-31) — Common Stock: 4406108.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 4406108.00
TIR.L balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1649065.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1649065.00
TIR.L cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3500481.00
TIR.L income_statement (annual, 2025-12-31) — Diluted Average Shares: 431686297.00
TIR.L income_statement (annual, 2025-12-31) — Diluted EPS: 0.00
TIR.L income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -1724003.00
TIR.L cash_flow (annual, 2025-12-31) — End Cash Position: 751994.00
TIR.L balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 587840.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 587840.00
TIR.L cash_flow (annual, 2025-12-31) — Financing Cash Flow: 3500481.00
TIR.L cash_flow (annual, 2025-12-31) — Free Cash Flow: -1636111.00
TIR.L cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 612019.00
TIR.L income_statement (annual, 2025-12-31) — General And Administrative Expense: 759647.00
TIR.L balance_sheet (annual, 2025-12-31) — Goodwill: 0.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Goodwill: 0.00
TIR.L balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 423200.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 423200.00
TIR.L income_statement (annual, 2025-12-31) — Interest Expense: 160173.00
TIR.L income_statement (annual, 2025-12-31) — Interest Income: 7134.00
TIR.L cash_flow (annual, 2025-12-31) — Interest Received Cfi: 7134.00
TIR.L cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1135833.00
TIR.L balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 587840.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 587840.00
TIR.L balance_sheet (annual, 2025-12-31) — Investments And Advances: 587840.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 587840.00
TIR.L cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3500481.00
TIR.L cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 3500481.00
TIR.L income_statement (annual, 2025-12-31) — Net Income: -1724003.00
TIR.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -1724003.00
TIR.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1724003.00
TIR.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1724003.00
TIR.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1724003.00
TIR.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -1724003.00
TIR.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -1724003.00
TIR.L income_statement (annual, 2025-12-31) — Net Interest Income: -153039.00
TIR.L cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -1142967.00
TIR.L cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 0.00
TIR.L balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1225865.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1225865.00
TIR.L income_statement (annual, 2025-12-31) — Normalized Income: -1724003.00
TIR.L cash_flow (annual, 2025-12-31) — Operating Cash Flow: -1636111.00
TIR.L income_statement (annual, 2025-12-31) — Operating Revenue: -477594.00
TIR.L balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 440160771.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 440160771.00
TIR.L cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: 500481.00
TIR.L balance_sheet (annual, 2025-12-31) — Other Equity Interest: 1395487.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1395487.00
TIR.L balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 423200.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 423200.00
TIR.L cash_flow (annual, 2025-12-31) — Other Non Cash Items: -179522.00
TIR.L income_statement (annual, 2025-12-31) — Other Operating Expenses: 324999.00
TIR.L balance_sheet (annual, 2025-12-31) — Other Payable: 723.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Other Payable: 723.00
TIR.L balance_sheet (annual, 2025-12-31) — Payables: 55054.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Payables: 55054.00
TIR.L balance_sheet (annual, 2025-12-31) — Prepaid Assets: 16243.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 16243.00
TIR.L income_statement (annual, 2025-12-31) — Pretax Income: -1724003.00
TIR.L cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1402155.00
TIR.L balance_sheet (annual, 2025-12-31) — Receivables: 19.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Receivables: 19.00
TIR.L income_statement (annual, 2025-12-31) — Rent And Landing Fees: 0.00
TIR.L income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 0.00
TIR.L balance_sheet (annual, 2025-12-31) — Retained Earnings: -6964639.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -6964639.00
TIR.L cash_flow (annual, 2025-12-31) — Sale Of Investment: 259188.00
TIR.L income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 51763.00
TIR.L income_statement (annual, 2025-12-31) — Selling General And Administration: 811410.00
TIR.L balance_sheet (annual, 2025-12-31) — Share Issued: 440610771.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 440610771.00
TIR.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1649065.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1649065.00
TIR.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1225865.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1225865.00
TIR.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TIR.L income_statement (annual, 2025-12-31) — Tax Provision: 0.00
TIR.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
TIR.L balance_sheet (annual, 2025-12-31) — Total Assets: 1779296.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 1779296.00
TIR.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1649065.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1649065.00
TIR.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 130231.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 130231.00
TIR.L balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 450000.00
TIR.L balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 450000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — +Operating Expense: 3863800000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — +Total Revenue: 19883700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 4642700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 1562000000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -2359900000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 197100000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -101200000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Amortization: 1200000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 1290000000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Basic EPS: 27.46
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 2265800000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 304800000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -736300000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Capital Expenditure Reported: -736300000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 41100000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 4248800000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 5536700000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -223400000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 2405300000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 1843500000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -1098500000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -246200000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 50700000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Change In Payable: 2318800000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -671100000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: 348800000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 1935000000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Common Stock: 102400000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -223400000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 10850100000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 636400000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 12146400000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Current Assets: 10310400000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 22200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Current Debt: 255500000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 277700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 5552700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 23500000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Depreciation: 565100000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 566300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 566300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 565100000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Diluted EPS: 27.46
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 2812300000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 13000000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 19900000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — EBIT: 3922800000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — EBITDA: 4489100000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 48000000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — End Cash Position: 4248800000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Financial Assets: 0.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -699800000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 427700000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 3287100000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -39500000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 0.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 112300000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 1663200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 8954500000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Gross Profit: 7737300000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 5300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Interest Expense: 169100000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 169100000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Interest Income: 50600000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 50600000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -186400000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 42700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Inventory: 2419600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 12459700000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -1388600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 1290000000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 707400000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 18900000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 1354100000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 1373000000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 0.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -245500000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 108600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 6819900000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: -4000000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Net Income: 2812300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 2812300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 2812300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 2812300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 2812300000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 3753700000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 2812300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Net Interest Income: -153100000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -714900000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -245500000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -245500000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -153100000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -414900000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Net PPE: 6594600000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 10849500000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 731500000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 108600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 415500000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 4489300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Normalized Income: 2812449520.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 4023400000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Operating Income: 3873500000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Operating Revenue: 19883700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 102388120.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 6200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 7000000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 10747700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 44400000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 127400000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 4800000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 11200000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 1108200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Payable: 252600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Properties: 486000000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 25700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 1287900000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Other Special Charges: -1000000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Payables: 5127000000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 23200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 23500000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 270700000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Pretax Income: 3753700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -18900000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 1762400000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 12146400000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 566300000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 24000000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 24000000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -245500000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Research And Development: 26400000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 484200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 8047100000.00
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 0.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1350600000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1462900000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Share Issued: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Special Income Charges: 1000000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 10850100000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 10849500000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -50480.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Tax Provision: 941400000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.25
TIRUMALCHM.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -733600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Total Assets: 18615900000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 12204200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Total Debt: 1650700000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 10850100000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Total Expenses: 16010200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 7765800000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 8305500000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 2213100000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 34600000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 218700000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -200000.00
TIRUMALCHM.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -200000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 185100000.00
TIRUMALCHM.NS balance_sheet (annual, 2022-03-31) — Working Capital: 4757700000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 4306100000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 21203300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 4970600000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1019300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -2822100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 197100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -101200000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Amortization: 700000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 700000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1323400000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Basic EPS: 8.77
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 4248800000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 407600000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -3627500000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure Reported: -3627500000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 728700000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 3495700000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 4585400000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -256000000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 1011100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 2484600000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -744200000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -554400000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -118200000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Change In Payable: 264600000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 521600000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -632800000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -990300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 102400000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -256000000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 11919200000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 4063900000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 15589000000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 10525400000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 62100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 2935800000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 2997900000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 8655100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 37400000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Depreciation: 556100000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 556800000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 556800000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 556100000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 8.77
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 898300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 13500000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 33700000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — EBIT: 1556100000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — EBITDA: 2112900000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 237200000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 3495700000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 0.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2058000000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 288100000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -3086200000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -33800000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -1100000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 194600000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1900000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1120500000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 13595300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Gross Profit: 5614300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 100000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Interest Expense: 262000000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 262000000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Interest Income: 165200000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 165200000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -362000000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 162600000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Inventory: 3191700000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 16330500000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -3589600000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1323400000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 3374700000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 707400000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 666600000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1475500000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2142100000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 3374700000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -654800000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 113500000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 7192200000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 915600000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -110700000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Net Income: 898300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 898300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 898300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 898300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 898300000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1294100000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 898300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -147300000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -167300000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2719900000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 2719900000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -147300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 10773200000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: 8900000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 11917300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 772500000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 113500000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 815300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 2102700000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Normalized Income: 891220180.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 541300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Operating Income: 1308200000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 21203300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 102388120.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 6200000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 8300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 11816800000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 1900000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 53400000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 125300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 163200000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 10700000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1610200000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 593600000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1224200000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 23400000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1089700000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Other Special Charges: -10500000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Payables: 5584100000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 26800000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 37400000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 825700000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Pretax Income: 1294100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -2500000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -682100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 2651600000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 15589000000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 556800000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 36800000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 36800000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -654800000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Research And Development: 25300000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 873600000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 8692900000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 514800000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 8900000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1182500000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1377100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Special Income Charges: 10500000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 11919200000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 11917300000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 3120180.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Tax Provision: 395800000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.31
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 133200000.00
TIRUMALCHM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -680800000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 23602400000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 13394700000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 5140000000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 11919200000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Total Expenses: 19895100000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 11683200000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 13077000000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 3028100000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 50500000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 6400000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 10200000.00
TIRUMALCHM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 10200000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 198600000.00
TIRUMALCHM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1870300000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 3927200000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 20715100000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 5163200000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1831500000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -3159000000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 197100000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -101200000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Amortization: 1000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 1000000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 1394100000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Basic EPS: -3.79
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 3495700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 507400000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -8107400000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure Reported: -8107400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 884200000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 4056000000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 4487000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -153600000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 2624300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1431700000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 687000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 385100000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -136800000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 449400000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -731500000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 1886500000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 488300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 102400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 11462100000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 11996100000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 16849900000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 11338400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 71900000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 3507800000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 3579700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 10288500000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 24400000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Depreciation: 631000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 632000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 632000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 631000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 102388120.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Diluted EPS: -3.79
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -387900000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 13500000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 73000000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — EBIT: 13400000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — EBITDA: 645400000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 72000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 4056000000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Financial Assets: 0.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 6426800000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 493800000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -5736900000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -73000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -500000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 171900000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1932700000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 22270100000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Gross Profit: 3865200000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 400000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Interest Expense: 358900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 358900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Interest Income: 105700000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 105700000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -791000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 88400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Inventories Adjustments Allowances: -800000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Inventory: 2508300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 23095200000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -8309000000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 1394100000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 12001600000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 707400000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 812300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 8125300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 8937600000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 12001600000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -4959100000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 147300000.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 7657000000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
TIRUMALCHM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 7577100000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 32400000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Net Income: -387900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -387900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -387900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -387900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -387900000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -345500000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -387900000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -311400000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -363800000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 7042500000.00
TIRUMALCHM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 7042500000.00
TIRUMALCHM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -311400000.00